2,12-DIBROMODECACYCLO-[9.9.0.0(1,8).(2,15).(3,17).0(5,12).0(6,10).0(11,18).0(16,20)]-ICOSANE
Compound with spectra: 1 NMR
![2,12-DIBROMODECACYCLO-[9.9.0.0(1,8).(2,15).(3,17).0(5,12).0(6,10).0(11,18).0(16,20)]-ICOSANE](/api/compound/J1jS8hnaoKu.png?ph=true&h=300&w=458 "2,12-DIBROMODECACYCLO-[9.9.0.0(1,8).(2,15).(3,17).0(5,12).0(6,10).0(11,18).0(16,20)]-ICOSANE")
| SpectraBase Compound ID | J1jS8hnaoKu |
|---|---|
| InChI | InChI=1S/C20H20Br2/c21-19-9-3-10-14-6-1-5(13(9)14)17(19)7-2-8-16-12(4-11(19)15(7)16)20(10,22)18(6,8)17/h5-16H,1-4H2/t5?,6?,7?,8?,9?,10?,11?,12?,13?,14?,15?,16?,17?,18?,19-,20- |
| InChIKey | RXGXKCUPURTQAT-LUXOQMEVSA-N |
| Mol Weight | 420.19 g/mol |
| Molecular Formula | C20H20Br2 |
| Exact Mass | 417.993177 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
13,15,17,20-TETRAOXADECACYCLO-[8.8.1.1(12,18).0(1,11).0(2,6).0(4,11).0(5,9).0(7,19).0(10,14).0(16,19)]-ICOSANE
6-(2-hydroxy-3,5-dimethylphenyl)-1,3-dimethyl-5-phenyl-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione
4-Chloro-17.alpha.-methyl-androsta-2,4-diene-3,17.beta.-diol, O,O'-bis-TMS
11,24-DIOXATRIDECACYCLO-[13.11.0.0(1,21).0(2,6).0(4,12).0(5,9).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20).0(22,26).0(23,25)]-HEXACOSANE
1,3-Dimethyl-6-phenyl-7-thioxo-5-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione
Dimethyl 3-chloro-5-methyl-4H-1,5,6,7,10b-tetrahydrobenzo[g]indolizine-1,2-dicarboxylate
5H-Phenanthro[8a,9-c]furan-2,7-dione, 1,3,4,7a,8,12b-hexahydro-3,10,11-trimethoxy-, (4aS*,7a.alpha.,12b.beta.)-
CUSSOVANTOSIDE-C
Kaempferol 3-O-.alpha.-L-rhamnoside, hexa-TMS
AUQQASLKDNQIPC-UHFFFAOYSA-N
| Title | Journal or Book | Year |
|---|---|---|
| The Pagodane Route to Dodecahedranes Directed Conversions – The Pagodane → Bissecododecahedradiene Stage | Chemische Berichte | 1992 |